← Open Payments lookup

MICHAEL COOPER: Open Payments

NPI 1386059277 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$607 in 39 payments from 12 companies in 2025. Trend: 2023 $1,109 · 2024 $22 · 2025 $607

Food & beverage: $607
CompanyPaymentsAmount
ABBVIE INC.17$169
E.R. Squibb & Sons, L.L.C.3$70
Alkermes, Inc.3$66
Takeda Pharmaceuticals U.S.A., Inc.3$64
Janssen Pharmaceuticals, Inc3$60
Neurocrine BioSciences, Inc.2$42
Otsuka America Pharmaceutical, Inc.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$29
Axsome Therapeutics, Inc.1$19
Supernus Pharmaceuticals, Inc.1$19

Products named: VRAYLAR, ARISTADA, TRINTELLIX, REXULTI, COBENFY, SPRAVATO, INGREZZA, CAPLYTA.

Industry payments across MO — which companies pay providers there.